文献速递角膜与眼表疾病

阿托伐醌通过调节线粒体功能和锌稳态抑制曲霉与镰刀菌角膜炎分离株生长

Atovaquone Impairs Growth of Aspergillus and Fusarium Keratitis Isolates by Modulating Mitochondrial Function and Zinc Homeostasis.
PubMed 文献 · Invest Ophthalmol Vis Sci · 2018-01-01

本研究在体外和小鼠模型中评估阿托伐醌对曲霉和镰刀菌的抗真菌作用。阿托伐醌对两种真菌临床分离株均有抗真菌活性,镰刀菌较曲霉更敏感,并降低细胞内不稳定锌水平、线粒体膜电位和ATP产生,与伏立康唑和伊曲康唑协同杀灭菌丝。局部应用阿托伐醌在小鼠真菌性角膜炎模型中显著抑制真菌生长和角膜混浊。

要点

  • 阿托伐醌对曲霉和镰刀菌临床分离株有抗真菌活性,镰刀菌更敏感。
  • 阿托伐醌降低细胞内不稳定锌水平,增加曲霉对金属应激的敏感性。
  • 阿托伐醌与伏立康唑和伊曲康唑协同杀灭菌丝,并降低线粒体膜电位和ATP产生。

核心结论

  • 阿托伐醌通过破坏金属稳态和线粒体功能,对丝状真菌具有显著的体外和体内抗真菌活性,因此有潜力成为新型抗真菌剂。

研究设计与样本

  • 体外实验:曲霉和镰刀菌发芽分生孢子与阿托伐醌过夜孵育,用荧光法测量菌丝生长。
  • 体内实验:C57BL/6小鼠角膜感染曲霉或镰刀菌分生孢子,局部添加阿托伐醌,量化角膜混浊和真菌生长。

主要发现

  • 阿托伐醌对曲霉和镰刀菌临床分离株有抗真菌活性,镰刀菌物种比曲霉物种更敏感。
  • 阿托伐醌降低细胞内不稳定锌水平并增加曲霉对金属应激的敏感性。
  • 阿托伐醌减少液泡酸化,并与伏立康唑和伊曲康唑协同杀灭菌丝。
  • 阿托伐醌处理后曲霉和镰刀菌的线粒体电位和ATP产生均降低。
  • 在小鼠真菌性角膜炎模型中,眼表局部应用阿托伐醌显著抑制真菌生长和角膜混浊。

临床怎么用

  • 原文未据此给出临床推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Aspergillus and Fusarium molds cause blinding corneal infections as a consequence of ocular trauma and in association with contact lens wear. As these fungi require zinc for fungal growth, we examined the effect of atovaquone, a ubiquinone analog that disrupts zinc homeostasis, on fungal growth in vitro and in vivo. METHODS: In vitro: Aspergillus and Fusarium germinating conidia were incubated overnight with atovaquone, and hyphal growth was measured by fluorimetry. In vivo: C57BL/6 mouse corneas were infected with Aspergillus or Fusarium conidia. Atovaquone was added topically and corneal opacification and fungal growth were quantified. RESULTS: Atovaquone has antifungal activity against Aspergillus and Fusarium clinical isolates, with Fusarium species being more sensitive to atovaquone than Aspergillus species. Atovaquone also reduced labile intracellular zinc levels and increased the sensitivity of Aspergillus to metal shock. Atovaquone reduced vacuolar acidification, which regulates storage of intracellular free zinc, and also acted synergistically with voriconazole and itraconazole to kill hyphae. Furthermore, mitochondrial potential and ATP production were reduced in both Aspergillus and Fusarium following atovaquone treatment. Finally, topical application of atovaquone to the ocular surface significantly inhibited fungal growth and corneal opacification in murine models of fungal keratitis. CONCLUSIONS: These studies demonstrate that atovaquone has pronounced in vitro and in vivo antifungal activity against filamentous fungi by disrupting both metal homeostasis and mitochondrial function, and therefore has potential as a novel antifungal agent.

来源:Invest Ophthalmol Vis Sci,查看原文。版权归原作者所有。

引用

  1. Clark HL, Minns MS, Sun Y, et al. Atovaquone Impairs Growth of Aspergillus and Fusarium Keratitis Isolates by Modulating Mitochondrial Function and Zinc Homeostasis. Invest Ophthalmol Vis Sci. 2018. PMID: 29625485. doi:10.1167/iovs.17-22585

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。